| Patents for A61P 1 - Drugs for disorders of the alimentary tract or the digestive system (125,798) |
|---|
| 09/12/2001 | EP1131358A1 Humanized antibody specific for surface antigen pre-s1 of hbv and preparation method thereof |
| 09/12/2001 | EP1131356A1 Method for inhibiting macrophage infiltration using monoclonal anti-alpha-d-antibodies |
| 09/12/2001 | EP1131340A2 Hexapeptide with the stabilized disulfide bond and derivatives thereof regulating metabolism, proliferation, differentiation and apoptosis |
| 09/12/2001 | EP1131337A1 Novel betulinic acid derivatives, processes for preparing such derivatives and its use as cancer growth inhibitors |
| 09/12/2001 | EP1131334A1 Use of core 2 glcnac transferase inhibitors in treating inflammation |
| 09/12/2001 | EP1131327A1 Prostaglandin conjugates for treating or preventing bone disease |
| 09/12/2001 | EP1131326A1 Phospholipid derivatives of non-steroidal anti-inflammatory drugs |
| 09/12/2001 | EP1131322A2 Dihydropyridine compounds and methods of use |
| 09/12/2001 | EP1131317A1 Method for preparing (2s)-1- (2r,3s)-5- chloro-3-(2- chlorophenyl) -1-(3,4-dimethoxy benzenesulphonyl) -3-hydroxy-2, 3-dihydro-1h- indole-2-carbonyl] pyrrolidine-2- carboxamide |
| 09/12/2001 | EP1131316A2 Improved chemical process and pharmaceutical formulation |
| 09/12/2001 | EP1131314A1 Compounds having cytokine inhibitory activity |
| 09/12/2001 | EP1131312A1 Novel pyrimidine derivatives and processes for the preparation thereof |
| 09/12/2001 | EP1131310A1 Chrystals of 5- 6-(2-fluorobenzyl)oxy-2-naphthyl methyl]-2,4-thiazolidinedione |
| 09/12/2001 | EP1131302A1 Substituted 4-amino-2-aryl-cyclopenta d]pyrimidines, their production and use and pharmaceuticalreparations containing same |
| 09/12/2001 | EP1131295A1 Quinoline-4-carboxamide derivatives as nk-3 and nk-2 receptor antagonists |
| 09/12/2001 | EP1131294A1 Quinoline derivatives as nk-2 and nk-3 receptor ligands |
| 09/12/2001 | EP1131083A1 Treatment of tumors by administration of growth hormone releasing compounds and their antagonists |
| 09/12/2001 | EP1131065A2 Utilisation of dialkylfumarates |
| 09/12/2001 | EP0822826B1 Nitrosylated neuropeptides |
| 09/12/2001 | EP0793665B1 Heterocyclic compounds and their preparation and use |
| 09/12/2001 | CN1312810A Substituted 1,8-naphthyridin-4(1H)-ones as phosphodiesterase 4 inhibitors |
| 09/12/2001 | CN1312806A Prodrugs of proton pump inhibitors |
| 09/12/2001 | CN1312805A Benzothiepines having activity as inhibitors of ileal bile acid transport and taurocholate uptake |
| 09/12/2001 | CN1312802A Cycloalkyl-substituted aryl-piperazines, piperidines and tetrahydropyridines as serotonergic agents |
| 09/12/2001 | CN1312800A Therapeutic biaryl derivatives |
| 09/12/2001 | CN1312720A Method and system for production and collection of lavage induced stool (LIS) for chemical and biologic tests of cells |
| 09/12/2001 | CN1312719A Pharmaceutical Composition |
| 09/12/2001 | CN1312717A Use of optically pure (+)-norcisapride for treating apnea, bulimia and other disorders |
| 09/12/2001 | CN1312714A Pharmaceutical composition containing lipase inhibitors and chitosan |
| 09/12/2001 | CN1312704A Incorporation of exogenous lact'c bacteria into oral microflora |
| 09/12/2001 | CN1312685A 碳水化合物混合物 Carbohydrate blend |
| 09/12/2001 | CN1312684A Protein component for dietetic food |
| 09/12/2001 | CN1312254A Novel nucleoside |
| 09/12/2001 | CN1312112A Cure-all ointment |
| 09/12/2001 | CN1312102A Life essence-filling, marrow-benefitting and kidney invigorating Chinese medicine preparation |
| 09/12/2001 | CN1312101A Vital energy benefitting menthol powder as one Chinese medicine preparation for treating gastrosis |
| 09/12/2001 | CN1312090A Chinese medicine for promoting height and intelligence growth |
| 09/12/2001 | CN1312077A Composite component comprising the effective extracts of licorice and lightyellow sophora and its application |
| 09/12/2001 | CN1312074A New application of benzene ring pelargonate hydrochloride |
| 09/12/2001 | CN1312068A Caries preventing antiphlogistic oral cavity preparation |
| 09/12/2001 | CN1070868C Peptides as therapeutic agents for treatment of auto-immune diseases |
| 09/12/2001 | CN1070867C Trefoil peptide dimer |
| 09/12/2001 | CN1070865C Peptides inhibiting release of pepsine |
| 09/12/2001 | CN1070709C Traditional Chinese medicinal preparation for treating hepatopathy and preparation method thereof |
| 09/11/2001 | US6288278 Benzene derived amino alcohols as drugs |
| 09/11/2001 | US6288277 Drugs, antiarthritic agants, antihistamines for treatment of asthma |
| 09/11/2001 | US6288267 Thioamide derivatives |
| 09/11/2001 | US6288231 Peptide-containing α-ketoamide cysteine and serine protease inhibitors |
| 09/11/2001 | US6288120 Prevention of loss and restoration of bone mass by certain prostaglandin agonists |
| 09/11/2001 | US6288084 Administering comounds such as 4-(4-chlorophenyl)-1-(4-(3-methoxyphenyl)-4-(3-pyridinyl)-3 -butenyl)piperidin-4-ol to treat diseases associated with aberrant leukocyte recruitment and/or activation |
| 09/11/2001 | US6288083 Chemokine receptor antagonists and methods of use therefor |
| 09/11/2001 | US6288081 Use of 7-(1-aminomethyl-2-oxa-7-aza-bicyclo[3.3.0]oct-7-yl)-quinolone carboxylic acid and naphthyridone carboxylic acid derivatives for treating Helicobacter pylori infections and the gastroduodenal diseases associated therewith |
| 09/11/2001 | US6288058 Treating muscular, nervous system, psychological and gastrointestinal disorders |
| 09/11/2001 | US6287816 BMP-9 compositions |
| 09/11/2001 | US6287786 Nucleic acid molecules encoding a new mammalian protein and to the use of these molecules in the characterization, diagnosis, and treatment of conditions such as disorders associated with cell proliferation, lipid metabolism and transport. |
| 09/11/2001 | US6287609 Unfermented gel fraction from psyllium seed husks |
| 09/11/2001 | US6287576 Biostimulating agent |
| 09/11/2001 | US6287555 Method and vaccine for prevention of over-production of acid in the rumen or gut of animals |
| 09/11/2001 | CA2230936C 5-azabicyclo(3.1.0)hexylalkyl-2-piperidones and -glutarimides as neurokinin receptor antagonists |
| 09/11/2001 | CA2209422C 4-amino-3-acylnaphthyridine derivatives |
| 09/11/2001 | CA2176205C Osteogenic product and process |
| 09/11/2001 | CA2057578C 1,4-disubstituted piperazines, process for their preparation and pharmaceutical compositions containing them |
| 09/07/2001 | WO2001064907A2 Lipid metabolism enzymes |
| 09/07/2001 | WO2001064885A1 Chordin-like-2 molecules and uses thereof |
| 09/07/2001 | WO2001064884A2 G12l, a gene associated with the thermal response |
| 09/07/2001 | WO2001064879A2 G-proteins coupled receptor related polypeptides |
| 09/07/2001 | WO2001064755A2 Isoxazole gegen virale erkrankungen |
| 09/07/2001 | WO2001064691A1 Il-8 receptor antagonists |
| 09/07/2001 | WO2001064690A1 Gastro-specific prodrugs |
| 09/07/2001 | WO2001064681A2 3-(pyrolyllactone)-2-indolinone compounds as kinase inhibitors |
| 09/07/2001 | WO2001064679A1 1,5-disubstituted-3,4-dihydro-1h-pyrimido[4,5-d]pyrimidin-2-one compounds and their use in treating csbp/p38 kinase mediated diseases |
| 09/07/2001 | WO2001064678A2 Inhibitors of hepatitis c virus ns3 protease |
| 09/07/2001 | WO2001064671A2 Haloimidazole derivatives and their use as muscarinic m3 and serotoninergic 5-ht4 receptors |
| 09/07/2001 | WO2001064670A1 Novel cyclic amide derivatives |
| 09/07/2001 | WO2001064669A1 Pyrazole ether derivatives as anti-inflammatory/analgesic agents |
| 09/07/2001 | WO2001064668A2 1,3-dihydro-2h-indol-2-one, and their use as v1b or both v1b and v1a arginine-vasopressin ligand receptors |
| 09/07/2001 | WO2001064662A1 Allomorph isomer z hydrochloride of ranitidine |
| 09/07/2001 | WO2001064634A1 Pharmaceutical compositions containing azetidine derivatives, novel azetidine derivatives and preparation thereof |
| 09/07/2001 | WO2001064633A1 Pharmaceutical compositions containing 3-amino-azetidine derivatives, novel derivatives and preparation thereof |
| 09/07/2001 | WO2001064632A1 Azetidine derivatives, preparation thereof and pharmaceutical compositions containing same |
| 09/07/2001 | WO2001064631A2 Derives de polyfluoroalkylimidazole et leur utilisation en tant qu'antagonistes des recepteur muscariniques m3 et serotoniques 5-ht4 |
| 09/07/2001 | WO2001064247A2 Method of treating cancer with anti-neurotrophin agents |
| 09/07/2001 | WO2001064221A1 Low dose entecavir formulation and use |
| 09/07/2001 | WO2001064215A1 Pharmaceutical composition for treatment and prevention of liver fibrosis and cirrhosis |
| 09/07/2001 | WO2001064214A2 Compositions and methods for the treatment of inflammatory diseases using topoisomerase inhibitors |
| 09/07/2001 | WO2001064208A1 Il-8 receptor antagonists |
| 09/07/2001 | WO2001064202A2 Tramadol for the treatment of functional gastrointestinal disorders |
| 09/07/2001 | WO2001064165A2 Il-8 receptor antagonists |
| 09/07/2001 | WO2001021761A3 Recombinant adenoviral vectors and their utility in the treatment of various types of fibrosis: hepatic, renal, pulmonary, as well as hypertrophic scars |
| 09/07/2001 | WO2001019823A3 Substituted pyridino pentaazamacrocyle complexes having superoxide dismutase activity |
| 09/07/2001 | WO2001019780A3 Novel derivatives of dicarboxylic acid having pharmaceutical properties |
| 09/07/2001 | WO2001016135A3 Reverse-turn mimetics and methods relating thereto |
| 09/07/2001 | WO2001010383A3 Caspase inhibitors and uses thereof |
| 09/07/2001 | WO2001005823A3 Tryptase inhibitor |
| 09/07/2001 | WO2000075107A3 Bradykinin receptor antagonists |
| 09/07/2001 | WO2000051584A3 Methods and compositions using (-) norcisapride in combination with proton pump inhibitors or h2 receptor antagonists |
| 09/07/2001 | WO2000047603A9 16-hydroxyestratrienes as selective estrogens |
| 09/07/2001 | CA2401697A1 Pyrazole ether derivatives as anti-inflammatory/analgesic agents |
| 09/07/2001 | CA2401660A1 Lipid metabolism enzymes |
| 09/07/2001 | CA2401659A1 Il-8 receptor antagonists |